Quadra Logic Technologies Inc. deal

QLTIF acquired an exclusive worldwide license to develop and market Ciba-Geigy Ltd.'s photodynamic therapy (PDT) drug, Zinc Phthalocyanine (ZnPc), as well as additional photosensitive compounds and complementary technology for PDT.

Ciba said it would focus its PDT activities in the ophthalmic area, leaving other applications to QLTIF. ...